Table 1.
Basic plasma parameters
Control Mice | ApoE KO Mice | ApoE KO with anti-LOX-1 Treatment | ApoE KO Mice with Adiponectin Treatment | |
---|---|---|---|---|
Body weight, g | 28.9 ± 2.4 | 27.7 ± 2.6 | 34.1 ± 3.2 | 30.9 ± 4.0 |
Abdominal girth, cm | 8.8 ± 0.2 | 8.5 ± 0.1 | 9.2 ± 0.4 | 9.1 ± 0.6 |
Total cholesterol, mg/dl | 297.3 ± 128.7 | 646.1 ± 49.1* | 486.8 ± 33.4*† | 514.8 ± 100.1 |
LDL, mg/dl | 9.3 ± 9.3 | 438.6 ± 170.0* | 539.1 ± 14.6* | 542.1 ± 4.7* |
HDL, mg/dl | 132.6 ± 39.9 | 35.5 ± 32.4* | 35.1 ± 30.0* | 46.4 ± 28.2*† |
Resistin, ng/ml | 7.9 ± 2.5 | 7.0 ± 1.7 | 7.7 ± 1.6 | 8.8 ± 2.7 |
Glucose, mg/dl | 174.9 ± 24.5 | 173.0 ± 46.4 | 182.2 ± 53.6 | 178.1 ± 62.4 |
Adiponectin, μg/ml | 4.4 ± 0.8 | 2.4 ± 0.9* | 4.6 ± 0.9† | 3.9 ± 0.7† |
LOX-1, ng/ml | 34.9 ± 15.8 | 96.7 ± 23.3* | 52.9 ± 28.6*† | 57.1 ± 39.2*† |
Data are means ± SD; n = 4–6 animals/group. ApoE, apolipoprotein E; KO, knockout; LOX-1: Lectin-like oxidized LDL receptor-1.
P < 0.05 vs. control mice;
P < 0.05 vs. ApoE KO mice.